RARE
Ultragenyx
14.50$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +1,863.9% | +1,871.5% | +101.4% | +161.3% | +29.7% | +3.4% | +19.5% | +29.0% | +20.1% | |
| – | – | – | – | – | +13,137.3% | -100.0% | +114,500.0% | +686.0% | -32.0% | +161.2% | +76.9% | +59.6% | +69.7% | +42.1% | |
| – | – | – | – | – | – | +1,863.2% | +1,828.3% | +88.1% | +179.7% | +26.6% | -0.1% | +16.1% | +24.3% | +16.6% | |
| – | +168.0% | +120.1% | +65.2% | +149.6% | +59.7% | +26.4% | +26.9% | +21.6% | +15.3% | +20.6% | +42.0% | -8.1% | +7.6% | +7.5% | |
| – | +81.3% | +33.1% | +142.9% | +205.3% | +96.8% | +53.9% | +27.8% | +26.5% | +13.3% | +20.3% | +26.4% | +11.4% | +3.8% | +8.5% | |
| – | +143.6% | +101.9% | +75.9% | +160.2% | +68.0% | +33.6% | +27.2% | +23.0% | +14.7% | +20.5% | +37.2% | -2.6% | +6.4% | +7.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | +2,833.1% | -11.6% | +46.2% | +53.4% | -4.5% | -1.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -241.1% | – | – | – | – | -46,382.9% | – | +538.7% | -63.2% | -13.5% | +445.6% | -132.0% | – | +150.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.